Blockchain Registration Transaction Record

NeuroOne Regains Nasdaq Compliance After Reverse Stock Split

NeuroOne Medical Technologies regains Nasdaq compliance after 1-for-6 reverse stock split. Learn about NMTC's FDA-cleared electrode and ablation systems for neurological disorders.

This news matters because it ensures NeuroOne continues to be publicly traded on Nasdaq, providing liquidity and access to capital markets for investors. The company's FDA-cleared electrode and ablation technologies are critical for patients with neurological disorders, offering less invasive surgical options that can reduce hospitalizations and improve outcomes. Maintaining listing compliance supports ongoing R&D for future treatments in drug delivery and spinal cord stimulation, potentially benefiting a broader patient population.